| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/17/2011 | WO2011031979A1 Pharmaceutically useful heterocycle-substituted lactams |
| 03/17/2011 | WO2011031658A1 Herbicidal pyrimidone derivatives |
| 03/17/2011 | WO2011031327A2 Nicotine haptens, immunoconjugates and their uses |
| 03/17/2011 | WO2011030872A1 Sulfonamide compounds |
| 03/17/2011 | WO2011030871A1 N-substituted heteroaryl compounds |
| 03/17/2011 | WO2011030868A1 Substituted carbonyl compounds |
| 03/17/2011 | WO2011030537A1 Process for production of 4-(5-methylpyridin-2-ylamino)piperidine-1-carboxylic acid derivatives |
| 03/17/2011 | WO2011030349A1 L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands |
| 03/17/2011 | WO2011030139A1 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
| 03/17/2011 | WO2011030068A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 03/17/2011 | WO2011029808A1 Hsl inhibitors useful in the treatment of diabetes |
| 03/17/2011 | WO2011029744A1 Sterically hindered amine stabilizer |
| 03/17/2011 | WO2011029537A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs |
| 03/17/2011 | WO2011029265A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof |
| 03/17/2011 | WO2011006803A8 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
| 03/17/2011 | WO2010144646A3 Anti-viral compounds to treat hcv infection |
| 03/17/2011 | US20110065924 Preparation of asymmetric anthracene derivatives and organic electroluminescent device using same |
| 03/17/2011 | US20110065919 5-Substituted Indol-3-Carboxylic Acid Derivatives Exhibiting Antiviral Activity a Method for the Production and Use Thereof |
| 03/17/2011 | US20110065918 New phenylalanine derivatives |
| 03/17/2011 | US20110065768 Non-steroidal androgens compounds |
| 03/17/2011 | US20110065755 Stable r(+)-lansoprazole amine salt and a process for preparing the same |
| 03/17/2011 | US20110065750 Solid Forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and Methods of Making the Same |
| 03/17/2011 | US20110065743 Kappa opioid receptor ligands |
| 03/17/2011 | US20110065736 Quinazoline derivatives as vegf inhibitors |
| 03/17/2011 | US20110065734 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 03/17/2011 | US20110065726 Organic Compounds |
| 03/17/2011 | US20110065725 Triazole amide derivatives for use in therapy |
| 03/17/2011 | US20110065720 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| 03/17/2011 | US20110065717 Sulfoximine derivatives as factor xa inhibitors |
| 03/17/2011 | US20110065713 Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors |
| 03/17/2011 | US20110065710 Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives |
| 03/17/2011 | US20110065707 New hsl inhibitors useful in the treatment of diabetes |
| 03/17/2011 | US20110065706 Therapeutic Agents 812 |
| 03/17/2011 | US20110065705 Compositions and Methods of Treating Cell Proliferation Disorders |
| 03/17/2011 | US20110065703 Novel agents of calcium ion channel modulators |
| 03/17/2011 | US20110065691 Therapeutic piperazines |
| 03/17/2011 | US20110065690 Compositions and methods for treatment of leukemia |
| 03/17/2011 | US20110065689 Therapeutic piperazines |
| 03/17/2011 | US20110065685 Novel indoles are cannabinoid receptor ligands |
| 03/17/2011 | US20110065684 Phthalazine derivatives as parp inhibitors |
| 03/17/2011 | US20110065683 Trisubstituted pyrazoles as acetylcholine receptor modulators |
| 03/17/2011 | US20110065682 Heterocyclic compounds as factor ixa inhibitors |
| 03/17/2011 | US20110065671 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 03/17/2011 | US20110065634 Glucagon receptor antagonists, compositions, and methods for their use |
| 03/17/2011 | US20110065577 Substituted pyridin-4-yl-methyl sulfonamides as fungicides |
| 03/17/2011 | US20110064698 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064697 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064696 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064695 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064657 Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents |
| 03/17/2011 | US20110063485 Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods |
| 03/17/2011 | US20110061723 Dye sensitised solar cell |
| 03/17/2011 | CA2774099A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof |
| 03/17/2011 | CA2773998A1 Substituted carbonyl compound |
| 03/17/2011 | CA2773848A1 Pi3 kinase inhibitors and uses thereof |
| 03/17/2011 | CA2773591A1 Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
| 03/17/2011 | CA2773464A1 A method for manufacturing 4-(5-methylpyridin-2-ylamino)piperidine-1-carboxylic acid derivative |
| 03/17/2011 | CA2772697A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 03/17/2011 | CA2771885A1 1,2-dihydro-2-oxoquinoline compounds as 5-ht4receptor ligands |
| 03/17/2011 | CA2771588A1 Herbicidal pyrimidone derivatives |
| 03/17/2011 | CA2771452A1 Hsl inhibitors useful in the treatment of diabetes |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295429A1 3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases |
| 03/16/2011 | EP2295428A2 Linear pyridazine and pyrrolic compounds, methods of preparation and applications |
| 03/16/2011 | EP2295427A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 03/16/2011 | EP2295426A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 03/16/2011 | EP2295425A1 1-substituted pyridyl-pyrazolyl amide compounds and uses thereof |
| 03/16/2011 | EP2295424A1 Processes for the preparation of novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase |
| 03/16/2011 | EP2295423A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives |
| 03/16/2011 | EP2295416A2 Triazole compounds that modulate HSP90 activity |
| 03/16/2011 | EP2295415A1 Quinazoline derivatives |
| 03/16/2011 | EP2295414A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295411A1 Pyrazoles as 11-beta-hsd-1 |
| 03/16/2011 | EP2295407A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 03/16/2011 | EP2295401A2 Deuterated hepatitis C protease inhibitors |
| 03/16/2011 | EP2295052A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450 |
| 03/16/2011 | EP2294065A1 Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 03/16/2011 | EP2294064A2 Process for purification of rabeprazole sodium |
| 03/16/2011 | EP2294063A1 Pyrrolidine ether derivatives as nk3 receptor antagonists |
| 03/16/2011 | EP2294062A1 Substituted 4- (indazolyl) -1,4-dihydropyridines and methods of use thereof |
| 03/16/2011 | EP2294061A2 Disubstituted phthalazine hedgehog pathway antagonists |
| 03/16/2011 | EP2294051A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them |
| 03/16/2011 | EP2205562B1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 03/16/2011 | EP2155683B1 Pyridone derivatives as p38a mapk inhibitors |
| 03/16/2011 | EP2132194B1 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 03/16/2011 | EP2125786B1 Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1h-pyrazol-3-yl) phenoxy)methyl)quinoline |
| 03/16/2011 | EP2091939B1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 03/16/2011 | EP2046758B1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/16/2011 | EP1940827B1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 03/16/2011 | EP1802606B1 Arylcarboxamides and their use as anti-tumor agents |
| 03/16/2011 | EP1703906B1 Immuno inhibitory pyrazolone compounds |
| 03/16/2011 | EP1699761B1 Cb1 modulator compounds |
| 03/16/2011 | EP1648878B9 Piperidine compounds and pharmaceutical compositions containing them |
| 03/16/2011 | EP1417186B1 Heterocyclic aryl sulphonamides |
| 03/16/2011 | EP1344777B1 Imidazole derivatives, process for their preparation and their use |
| 03/16/2011 | CN101985444A V crystal form of Fasudil hydrochloride and preparation method and application thereof |
| 03/16/2011 | CN101985443A Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 03/16/2011 | CN101985442A Convenient and quick method for preparing high-purity imatinib and mesylate thereof |